Durham, NC, United States of America

Clifford W Sachs

This inventor holds 1 USPTO granted patent. Top assignees: Duke University, Pharmaceuticals Corporation. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clifford W Sachs. Retrieved from https://idiyas.com/inventor/clifford-w-sachs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Clifford W Sachs

Introduction

Clifford W Sachs is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in combating multidrug resistance in cancer treatment. His innovative work has the potential to enhance the effectiveness of antineoplastic agents.

Latest Patents

Sachs holds a patent for "Aminoanthraquinone derivatives to combat multidrug resistance." This patent focuses on potentiating agents that inhibit the development of multidrug resistance, reduce drug-resistance in drug-resistant tumors, or sensitize tumors to antineoplastic drugs. The potentiating agents are aminoanthraquinones, preferably 1,4-bis(N-substituted) amino anthraquinones, and pharmaceutically acceptable salts thereof. He has 1 patent to his name.

Career Highlights

Throughout his career, Sachs has worked with esteemed institutions such as Duke University and Pharmaceuticals Corporation. His research has been pivotal in advancing the understanding of drug resistance in cancer therapy.

Collaborations

Sachs has collaborated with notable colleagues, including Robert L Fine and Lawrence M Ballas. Their combined expertise has contributed to the development of innovative solutions in the pharmaceutical field.

Conclusion

Clifford W Sachs is a distinguished inventor whose work in aminoanthraquinone derivatives has the potential to revolutionize cancer treatment by addressing multidrug resistance. His contributions to the field are invaluable and continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…